Dr. Lifschitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Shaare Zedek Medical Center
Jerusalem, Israel
FPO, AP 96427
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 1971 - 1973
- University of California (San Diego) Medical CenterInternship, Internal Medicine, 1970 - 1971
- University of Pennsylvania Health SystemInternship, Internal Medicine, 1967 - 1968
- Boston University School of MedicineClass of 1967
- Boston UniversityMA, Physiology, 1966
- Massachusetts Institute of TechnologyBS, 1963
Certifications & Licensure
- TX State Medical License 2004 - 2028
- DC State Medical License 2007 - 2013
Awards, Honors, & Recognition
- Alpha Omega Alpha Begg Society, 1966
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 2 citationsRenal Perfusion and Renal Nerve ActivityMeyer Lifschitz
Journal of the American Society of Nephrology. 2019-02-13 - 13 citationsThe Unappreciated Role of Extrarenal and Gut Sensors in Modulating Renal Potassium Handling: Implications for Diagnosis of Dyskalemias and Interpreting Clinical TrialsMurray Epstein, Meyer D. Lifschitz
Kidney International Reports. 2016-05-01 - 8 citationsPotassium homeostasis and dyskalemias: the respective roles of renal, extrarenal, and gut sensors in potassium handling.Murray Epstein, Meyer D. Lifschitz
Kidney International Supplements. 2016-04-01
Journal Articles
- Preoperative Renal Dysfunction and Anemia Predict outcomes after cardiac surgeryLinda Shavit, Meyer Lifschitz, Rachel Tauber, Daniel Bitran and Daniel Fink, CJASN, 7/1/2014
- Long-term Hypoparathyroidism and Hypophosphatemia in a Dialysis PatientL Shavit, M Lifschitz and I Slotki, Journal of Investigative Medicine High Impact Case Reports, 5/1/2014
- Pegylated liposomal do:xorubicin and renal thrombotic microangiopathy: an under recognized complication of prolonged treatmentL Shavit, M Lifschitz et al, Kidney Inter, 1/1/2014
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: